aliquot

Melanocortin-related

PT-141 / Bremelanotide

An Aliquot catalog identity that names PT-141 with bremelanotide, with an FDA bremelanotide label and route-specific pharmacokinetic information.

Canonical ID
pt-141
Evidence type
FDA regulatory record
Human PK
2.7 hours

Overview

Aliquot publishes a restrained evidence record for this catalog identity. The page is descriptive and is not a guide to selection, dosing, administration, or treatment.

The public record is limited to identity, regulatory status, and pharmacokinetic context. Aliquot does not summarize outcomes or recommend use.

Human pharmacokinetic context

2.7 hours

FDA prescribing information · subcutaneous injection

Half-life is descriptive population context, not a dosing interval, a prediction of an individual's response, or a recommendation. Route-mismatched and uncited estimates are withheld.

Limitations

  • The FDA label applies to the named approved bremelanotide product and labeled use.
  • A population half-life is not a prediction for an individual or a regimen.

Related calculation tools

Aliquot's browser-only tools transform values you already have. They do not select a compound, suggest an amount, provide presets, or store your entries.

View all tools Convert mg and mcg

Sources

  1. Vyleesi (bremelanotide) prescribing information FDA prescribing information · U.S. Food and Drug Administration · accessed 2026-07-28 Regulatory status and terminal half-life.
  2. Aliquot compound library methodology Editorial methodology · Aliquot · accessed 2026-07-28 Editorial scope and withholding rules.

Aliquot Compound Library

Before you browse

Aliquot's Compound Library is an educational reference. Here is how to read and use it.

Educational, not medical advice

The library does not diagnose, treat, prevent, recommend a compound, or replace a licensed clinician. Consult a qualified clinician for personal health decisions.

Evidence has boundaries

Summaries draw from cited public regulator records, peer-reviewed human studies, PubMed records, and trial registrations. A citation does not make a claim conclusive.

No community health profiles

Aliquot does not collect community protocols or outcomes for this library. Calculator entries remain in your browser tab and are not submitted or saved.

Content and reuse

Aliquot's original editorial text and presentation may not be copied, scraped, mirrored, or redistributed without written permission. Linked sources remain subject to their publishers' terms.

This acknowledgement is stored only in this browser. No health or calculator data is included.

Methodology Terms

Reviewed by Aliquot editorial review on 2026-07-28. Next scheduled review: 2026-10-26. Methodology and corrections.